REFERENCES
1. Morrissey BJ, Bycroft TP, Almossawi O, Wilkey OB, Daniels JG. Incidence and Predictors of Bacterial infection in Febrile Children with Sickle Cell Disease. Hemoglobin. 2015;39(5):316–9.
2. Cannas G, Merazga S, Virot E. Sickle cell disease and infections in high- and low-income countries. Mediterr J Hematol Infect Dis. 2019;11(1):1–9.
3. Narang S, Fernandez ID, Chin N, Lerner N, Weinberg GA. Bacteremia in children with sickle hemoglobinopathies. J Pediatr Hematol Oncol. 2012; 34:13–16.
4. Bansil NH, Kim TY, Tieu L BB. Incidence of Serious Bacterial Infections in Febrile Children With Sickle Cell Disease. Clin Pediatr (Phila). 2013;52(7):661–6.
5. Rincón-López EM, Navarro Gómez ML, Hernández-Sampelayo Matos T, Saavedra-Lozano J, Aguilar de la Red Y, Hernández Rupérez B, et al. Low-risk factors for severe bacterial infection and acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer. 2019;66(6):1–7.
6. Chang TP, Kriengsoontorkij W, Chan LS, Wang VJ. Predictors for Bacteremia in Febrile Sickle Cell Disease Children in the Post-7-Valent Pneumococcal Conjugate Vaccine Era. J Pediatr Hematol Oncol. 2013;35:377–382.
7. Elenga N, Placide L, Cuadro-alvarez E, Long L, Razafindrakoto SH, Mrsic Y, et al. Does Procalcitonin Predict Bacterial Infection in Febrile Children with Sickle Cell Disease? Indian J Pediatr. 2019;86(1):95–96.
8. Savlov D, Beck CE, DeGroot J, Odame I, Friedman JN. Predictors of Bacteremia Among Children With Sickle Cell Disease Presenting With Fever. J Pediatr Hematol Oncol. 2014;36(5):384–8.
9. West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N. Predictors of Bacteremia in Febrile Children With Sickle Cell Disease. J Pediatr Hematol Oncol. 2002;24(4):279-83.
10. Olenscki Gilli SC, Pericole FV, Benites BD, Sippert EÂ, Castilho LM, Addas-Carvalho M, et al. Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression. Exp Hematol. 2016;44(7):583–9.
11. Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, et al. Exp Biol Med (Maywood). 2005;230(1):68–74.
12. Taylor SC, Shacks SJ, Mitchell RA, Banks A. Serum Interleukin-6 Levels in the Steady State of Sickle Cell Disease. J Interf Cytokine Res. 1995;15(12):1061–4.
13. Taylor SC, Shacks SJ, Qu Z, Wiley P. Type 2 Cytokine Serum Levels in Healthy Sickle Cell Disease Patients. J Natl Med Assoc. 1997;89(11):753–7.
14. Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D. Cytokine profile of sickle cell disease in Oman. Am J Hematol. 2004;77(4):323–8.
15. Sarray S, Saleh LR, Lisa Saldanha F, Al-Habboubi HH, Mahdi N, Almawi WY. Serum IL-6, IL-10, and TNFa levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine. 2015;72(1):43–7.
16. Ploton MC, Sommet J, Koehl B, Gaschignard J, Holvoet L, Mariani-Kurkdjian P, et al. Respiratory pathogens and acute chest syndrome in children with sickle cell disease. Arch Dis Child. 2020;105(9):891–5.
17. Srinivasan A, Wang WC, Gaur A, Smith T, Gu Z, Kang G, et al. Prospective Evaluation for Respiratory Pathogens in Children With Sickle Cell Disease and Acute Respiratory Illness. Pediatr Blood Cancer. 2014;61:507–11.
18. Cela, E, Ruiz, A, Cervera Á. Enfermedad de células falciformes. Guía de práctica clínica de la Sociedad Española de Hematología y Oncología Pediátricas. CeGe, editor. 2019. Available from: http://www.sehop.org/wp-content/uploads/2019/03/Guía-SEHOP-Falciforme-2019.pdf
19. Buchanan G. Evidence-Based Management of Sickle Cell Disease. NIH Expert panel report 2014. Available from: https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-disease-report 020816_0.pdf
20. Noronha SA, Sadreameli SC, Strouse JJ. Management of Sickle Cell Disease in Children. South Med J. 2016;109(9):495–502.
21. Shao WX, Yu DJ, Zhang WY, Wang XJ. Clinical significance of interleukin-6 in the diagnosis of sepsis and discriminating sepsis induced by gram-negative bacteria. Pediatr Infect Dis J. 2018;37(8):801–5.
22. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–57.
23. Slaats J, ten Oever J, van de Veerdonk FL, Netea MG. IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLoS Pathog. 2016;12(12):1–13.
24. Holub M, Lawrence DA, Andersen N, Davidová A, Beran O, Marešová V, et al. Cytokines and chemokines as biomarkers of community-acquired bacterial infection. Mediators Inflamm. 2013;2013:190145.
25. Cernada M, Badía N, Modesto V, Alonso R, Mejías A, Golombek S, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr Int J Paediatr. 2012;101(5):203–7.
26. Tasci Y, Dilbaz B, Uzmez Onal B, Caliskan E, Dilbaz S, Doganci L, et al. The value of cord blood interleukin-6 levels for predicting chorioamnionitis, funisitis and neonatal infection in term premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):34–9.
27. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989;169(1):333–8.
28. Bal ZŞ, Özdemir NK, Şen S, Karapınar DY, Azarsız E, Aydemir Ş, et al. Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia. Turkish J Hematol. 2017;34(3):254–7.
29. Diepold M, Noellke P, Duffner U, Kontny U, Berner R. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008;8:2–8.
30. Nascimento-Carvalho EC, Vasconcellos ÂG, Clarêncio J, Andrade D, Barral A, Barral-Netto M, et al. Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies. Pediatr Pulmonol. 2020;55(1):169–76.
31. Vasconcellos ÂG, Clarêncio J, Andrade D, Cardoso MRA, Barral A, Nascimento-Carvalho CM. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia. Cytokine. 2018;107:1–8.
32. Fuchs A, Gotta V, Decker ML, Szinnai G, Baumann P, Bonhoeffer J, et al. Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial. Clin Microbiol Infect. 2018;24(12):1341.
33. Calbo E, Alsina M, Rodríguez-Carballeira M, Lite J, Garau J. Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: Effects of treatment with a β-lactam versus a fluoroquinolone. Antimicrob Agents Chemother. 2008;52(7):2395–402.
34. Adegoke SA, Smith OS, Adekile AD, Figueiredo MS. Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease. Cytokine. 2017;96:87–93.